Long-term use of proton pump inhibitors (PPIs) without an ongoing indication or evidence of benefit contributes to increased pill burden, increased medication-related costs, and potential adverse effects. This written article reviews FDA-approved labeling for PPIs, summarizes treatment guidelines regarding appropriate dosage and duration of treatment, and is designed to help learners identify appropriate indications for long-term use of PPIs. In the absence of an indication for long-term use, recommendations are provided to assist with developing patient-specific plans to deprescribe PPIs and manage symptoms. Program Objectives Identify the appropriate dosing and duration of PPIs based on FDA-approved indications and guideline recommendations. Discuss considerations for long-term PPI therapy. Determine when deprescribing of PPIs is appropriate based on patient-specific factors.
- Provider:The University at Buffalo Jacobs School of Medicine and Biomedical Sciences
- Activity Link: https://pharmacy.buffalo.edu/academics/continuing-education/events/ppi-stewardship.html
- Start Date: 2023-08-14 05:00:00
- End Date: 2023-08-14 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance, Patient Health
- Provider Ship: Directly Provided
- Registration: Open to all